Yield10 Bioscience, Inc. (YTEN) Financials

$0.34

south_east
-$0 (0%)
Day's range
$0.34
Day's range
$0.34

YTEN Income statement / Annual

Last year (2023), Yield10 Bioscience, Inc.'s total revenue was $60,000.00, a decrease of 86.67% from the previous year. In 2023, Yield10 Bioscience, Inc.'s net income was -$14.46 M. See Yield10 Bioscience, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $60,000.00 $450,000.00 $614,000.00 $799,000.00 $806,000.00 $556,000.00 $944,000.00 $1.16 M $2.59 M $2.80 M
Cost of Revenue $290,000.00 $656,000.00 $578,000.00 $5.22 M $4.85 M $4.78 M $4.60 M $5.67 M $660,000.00 $1.48 M
Gross Profit -$230,000.00 -$206,000.00 $36,000.00 -$4.42 M -$4.04 M -$4.23 M -$3.65 M -$4.51 M $1.93 M $1.32 M
Gross Profit Ratio -3.83 -0.46 0.06 -5.53 -5.01 -7.6 -3.87 -3.89 0.75 0.47
Research and Development Expenses $8.32 M $7.75 M $6.20 M $5.36 M $4.85 M $4.78 M $4.60 M $5.67 M $16.57 M $17.34 M
General & Administrative Expenses $6.15 M $6.15 M $6.11 M $5.05 M $4.55 M $5.09 M $5.63 M $5.74 M $9.11 M $10.81 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $6.15 M $6.15 M $6.11 M $5.05 M $4.55 M $5.09 M $5.63 M $5.74 M $9.11 M $10.81 M
Other Expenses $0.00 $41,000.00 -$3,000.00 $83,000.00 $21,000.00 $134,000.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $14.48 M $13.90 M $12.31 M $10.41 M $9.40 M $9.88 M $10.23 M $11.41 M $25.68 M $28.15 M
Cost And Expenses $14.48 M $13.90 M $12.31 M $10.41 M $9.40 M $9.88 M $10.23 M $11.41 M $26.34 M $29.63 M
Interest Income $0.00 $0.00 $0.00 $0.00 $96,000.00 $158,000.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $13.02 M $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $290,000.00 $656,000.00 $578,000.00 $611,000.00 $1.83 M $784,000.00 $206,000.00 $177,000.00 $265,000.00 $507,000.00
EBITDA -$14.13 M -$13.19 M -$11.47 M -$9.43 M -$8.39 M -$9.12 M -$9.08 M -$10.07 M -$12.35 M -$26.32 M
EBITDA Ratio -235.45 -29.31 -19.82 -11.02 -6.1 -16.41 -9.5 -8.36 -9.07 -9.42
Operating Income Ratio -240.28 -29.89 -19.04 -12.03 -10.67 -16.76 -9.83 -8.84 -9.15 -9.58
Total Other Income/Expenses Net -$38,000.00 $41,000.00 $697,000.00 -$541,000.00 -$4.61 M $134,000.00 -$113,000.00 -$38,000.00 $29,000.00 $61,000.00
Income Before Tax -$14.46 M -$13.41 M -$11.00 M -$10.15 M -$13.21 M -$9.19 M -$9.40 M -$10.29 M -$23.68 M -$26.77 M
Income Before Tax Ratio -240.92 -29.8 -17.91 -12.7 -16.39 -16.52 -9.95 -8.87 -9.13 -9.56
Income Tax Expense $0.00 $156,000.00 $36,000.00 $56,000.00 -$254,000.00 $104,000.00 $113,000.00 -$1.10 M -$62,000.00 $2.71 M
Net Income -$14.46 M -$13.57 M -$11.03 M -$10.21 M -$12.96 M -$9.19 M -$9.40 M -$7.60 M -$23.68 M -$29.53 M
Net Income Ratio -240.92 -30.15 -17.97 -12.77 -16.07 -16.52 -9.95 -6.56 -9.13 -10.55
EPS -43.66 -66.25 -55.95 -103.21 -851.98 -887.78 -2771.06 -2651.74 -9184.37 -27966.3
EPS Diluted -43.66 -66.25 -55.95 -103.21 -851.98 -887.78 -2771.06 -2651.74 -9184.37 -27966.3
Weighted Average Shares Out $331,095.00 $204,774.00 $197,160.00 $98,886.00 $15,207.00 $10,346.00 $3,390.76 $2,867.55 $2,578.40 $1,056.06
Weighted Average Shares Out Diluted $331,095.00 $204,774.00 $197,160.00 $98,886.00 $15,207.00 $10,346.00 $3,390.76 $2,867.55 $2,578.40 $1,056.06
Link